GS
ELV icon

GTS Securities’s Elevance Health ELV Stock Holding History

GTS Securities’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-26,400
Closed -$13.7M – 2105
2024
Q3 		$13.7M Buy
26,400
+1,100
+4% +$588K 0.03% 383
2024
Q2 		$13.7M Buy
25,300
+1,500
+6% +$793K 0.03% 377
2024
Q1 		$12.3M Sell
23,800
-8,700
-27% -$4.33M 0.02% 425
2023
Q4 		$15.3M Sell
32,500
-6,500
-17% -$3.01M 0.03% 428
2023
Q3 		$17M Buy
+39,000
New +$17.7M 0.03% 385

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

GTS Securities's ELV Position: Q1 2026 in Review

GTS Securities reduced its Elevance Health (ELV) stake by 62% in Q1 2026, selling an estimated $518K and leaving 975 shares worth $285K. The position accounts for 0.01% of the portfolio, ranked #1136.

GTS Securities first reported a position in ELV in Q3 2023 and has held it in 10 quarters since. The position peaked at $2.08M in Q4 2023. 1,464 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • GTS Securities held 975 shares of Elevance Health worth $285K as of Q1 2026.
  • GTS Securities sold 1,577 Elevance Health shares in Q1 2026, an estimated $518K.
  • Elevance Health made up 0.01% of GTS Securities's portfolio in Q1 2026, its #1136 holding.
  • GTS Securities first reported a position in Elevance Health in Q3 2023 and has held it in 10 quarters since.
  • GTS Securities's Elevance Health position peaked at $2.08M in Q4 2023.
  • 1,464 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on GTS Securities's 13F filing for Q1 2026, filed 15 May 2026.